How long does Zometa take to infuse?
Zometa infusions are given by a healthcare provider over a period of at least 15 minutes. It’s typically done at a healthcare facility, but in some cases, a healthcare provider may give you the drug in your home. For hypercalcemia caused by cancer, Zometa is given as a single dose.
How do you give Zometa infusion?
This medication is given by injection into a vein as directed by your doctor, usually over at least 15 minutes. The dosage is based on your medical condition (including your kidney function) and response to treatment.
How often is Zometa infusion given?
Both Zometa and Aredia are given intravenously, usually every 4 weeks. A study suggests that after being treated with the regular dose of Zometa and/or Aredia for a year, women with bone metastases can get Zometa every 12 weeks and still get the same benefits from the medicine while reducing their risk of side effects.
Is Zometa infusion chemotherapy?
Zoledronic acid (Zometa) is not cancer chemotherapy, and it will not slow or stop the spread of cancer. However, it can be used to treat bone disease in patients who have cancer. Zoledronic acid is in a class of medications called bisphosphonates.
How do you infuse zoledronic acid?
Intravenous use. Zoledronic Acid (5 mg in 100 ml ready-to-infuse solution) is administered via a vented infusion line and given slowly at a constant infusion rate. The infusion time must not be less than 15 minutes.
How do you dilute zoledronic acid?
Vials of Zometa concentrate for infusion contain overfill allowing for the withdrawal of 5 mL of concentrate (equivalent to 4 mg zoledronic acid). This concentrate should immediately be diluted in 100 mL of sterile 0.9% Sodium Chloride, USP, or 5% Dextrose Injection, USP.
How is zoledronic acid infusion administered?
How do you feel after a Zometa infusion?
Within three days after Zometa administration, an acute phase reaction has been reported in patients, with symptoms including pyrexia, fatigue, bone pain and/or arthralgias, myalgias, chills, and influenza-like illness. These symptoms usually resolve within a few days.
How is zoledronic administered?
The recommended dose for the treatment of postmenopausal osteoporosis is 5 mg of zoledronic acid in 100 mL ready to infuse solution. It is administered intravenously via a vented infusion line. The infusion time must not be less than 15 minutes and the infusion rate should be constant.
How long does a bone infusion take?
IV infusions of Reclast take 30 minutes to complete. For treatment of osteoporosis, patients receive one 5mg dose per year. For all treatments, supplementation with calcium and Vitamin D is generally prescribed. Consult your doctor or infusion provider for more information about Reclast dosing.
Does zoledronic acid need to be refrigerated?
After first opening, Zoledronic Acid should be used immediately. If the solution is not used immediately, it should be stored in a refrigerator at 2°C – 8°C but no longer than 24 hours.
How much is Zometa?
The cost for Zometa intravenous solution (4 mg/100 mL) is around $973 for a supply of 100 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans. A generic version of Zometa is available, see zoledronic acid prices.
Why did they change the duration of Zometa infusion?
The studies were amended twice because of renal toxicity. The Zometa infusion duration was increased from 5 minutes to 15 minutes. After all patients had been accrued, but while dosing and follow-up continued, patients in the 8 mg Zometa treatment arm were switched to 4 mg due to toxicity.
How do you administer Zometa infusion?
Zometa should be administered via intravenous infusion over at least 15 minutes. Zometa contains the bisphosphonate drug zoledronic acid. It prevents bone resorption by osteoclasts. Zometa binds to mineralized bone, thereby blocking the action of osteoclasts on the bone.
What is the maximum dose of Zometa for renal failure?
Due to the risk of clinically significant deterioration in renal function, which may progress to renal failure, single doses of Zometa should not exceed 4 mg and the duration of infusion should be no less than 15 minutes.
Is Zometa effective in the treatment of hypercalcemia of malignancy in elderly patients?
Clinical studies of Zometa in hypercalcemia of malignancy included 34 patients who were 65 years of age or older. No significant differences in response rate or adverse reactions were seen in geriatric patients receiving Zometa as compared to younger patients.